Mild to moderate renal impairment is associated with increased left ventricular mass

Kim Greaves1, Ruoling Chen, Lei Ge

  • 1Poole Hospital and Bournemouth University, UK. kim.greaves@poole.nhs.uk

Abstract

Insights

Mild to moderate renal impairment (MMRI) is linked to higher cardiovascular risk. This study found that even mild kidney dysfunction is independently associated with increased left ventricular mass (LVM) in patients with chest pain.

Area of Science:

  • Cardiology
  • Nephrology
  • Internal Medicine

Background:

  • Mild to moderate renal impairment (MMRI) is linked to increased cardiovascular mortality, but the underlying mechanisms are not fully understood.
  • Increased left ventricular mass (LVM) is a known risk factor for cardiovascular events, particularly in severe kidney disease.
  • The association between MMRI and LVM in patients undergoing investigation for chest pain remains unclear.

Purpose of the Study:

  • To investigate the relationship between mild to moderate renal impairment and left ventricular mass in patients presenting with chest pain.
  • To determine if MMRI is an independent predictor of increased LVM in this patient population.

Main Methods:

  • A cohort of 336 consecutive patients undergoing coronary angiography for chest pain were assessed.
  • Renal function was evaluated using serum creatinine (Cr), creatinine clearance (CrCl), and glomerular filtration rate (GFR).
  • Left ventricular mass normalized for body surface area (NLVM) was measured concurrently with renal function and coronary angiography.

Main Results:

  • NLVM showed significant correlations with Cr, CrCl, and GFR (all p<0.001).
  • Patients with MMRI, defined by specific ranges of Cr, CrCl, and GFR, exhibited significantly increased NLVM.
  • Multiple regression analysis confirmed that MMRI was independently associated with increased NLVM (e.g., OR 2.77 for Cr 1.2-1.9 mg/dL, p=0.04).

Conclusions:

  • Mild to moderate renal impairment is significantly and independently associated with increased left ventricular mass in patients investigated for chest pain.
  • These findings suggest that MMRI may contribute to cardiovascular risk through cardiac remodeling, even in the early stages of kidney dysfunction.

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...